ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01ED03 | B | Alectinib - 150mg | 9459/388 | 178617/1 | ALECENSA | 150mg | 224 | Capsule, hard | Oral | Omnipharma | Excella GmbH | Germany | L.L | 2.44 | E2 | F. Hoffmann La Roche Ltd | Switzerland | 2/5/2024 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01ED03 | B | Alectinib - 150mg | 9459 | 178617/1 | ALECENSA | 150mg | 224 | Capsule, hard | Oral | Omnipharma | Excella GmbH | Germany | 490,837,809 L.L | 2.44 | E2 | F. Hoffmann La Roche Ltd | Switzerland | 2/5/2024 | 0 |